Monday, November 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials

Journal of diabetes and metabolic disorders · 2026 Dec · Wajid R, Kumar R, Muneer M et

MH
By Maren Holt · Senior Reporter, GLP-1

From the source

Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials

Journal of diabetes and metabolic disorders · 2026 Dec · Wajid R, Kumar R, Muneer M et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →